227 related articles for article (PubMed ID: 8925845)
1. Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid.
Barrington SF; Kettle AG; O'Doherty MJ; Wells CP; Somer EJ; Coakley AJ
Eur J Nucl Med; 1996 Feb; 23(2):123-30. PubMed ID: 8925845
[TBL] [Abstract][Full Text] [Related]
2. Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism.
Barrington SF; O'Doherty MJ; Kettle AG; Thomson WH; Mountford PJ; Burrell DN; Farrell RJ; Batchelor S; Seed P; Harding LK
Eur J Nucl Med; 1999 Jul; 26(7):686-92. PubMed ID: 10398815
[TBL] [Abstract][Full Text] [Related]
3. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
[TBL] [Abstract][Full Text] [Related]
4. Thyroid cancer: radiation safety precautions in 131I therapy based on actual biokinetic measurements.
Liu B; Peng W; Huang R; Tian R; Zeng Y; Kuang A
Radiology; 2014 Oct; 273(1):211-9. PubMed ID: 24895877
[TBL] [Abstract][Full Text] [Related]
5. Management of 131I therapy for thyroid cancer: cumulative dose from in-patients, discharge planning and personnel requirements.
Pacilio M; Bianciardi L; Panichelli V; Argirò G; Cipriani C
Nucl Med Commun; 2005 Jul; 26(7):623-31. PubMed ID: 15942483
[TBL] [Abstract][Full Text] [Related]
6. Management of the helpless patient after radioiodine ablation therapy - are we being too strict?
Williams CE; Woodward AF
Nucl Med Commun; 2005 Oct; 26(10):925-8. PubMed ID: 16160653
[TBL] [Abstract][Full Text] [Related]
7. Recommended restrictions after 131I therapy: measured doses in family members.
Mathieu I; Caussin J; Smeesters P; Wambersie A; Beckers C
Health Phys; 1999 Feb; 76(2):129-36. PubMed ID: 9929123
[TBL] [Abstract][Full Text] [Related]
8. Thyroid remnant ablation using 1,110 MBq of I-131 after total thyroidectomy: regulatory considerations on release of patients after unsealed radioiodine therapy.
Kusakabe K; Yokoyama K; Ito K; Shibuya H; Kinuya S; Ito M; Higashi T; Togawa T; Koizumi K; Yoshimura M; Uchiyama M; Okamoto T; Kanaya S; Kanaya K; Yoneyama T; Ikebuchi H; Yanagida S; Shibata K; Segawa K; Yamamoto A
Ann Nucl Med; 2012 May; 26(4):370-8. PubMed ID: 22450825
[TBL] [Abstract][Full Text] [Related]
9. Thyroid remnant ablation with 1110MBq of 131I in outpatients: measurement of effective dose to household members and establishment of safety precautions.
Yoshimura M; Tsutsui H; Ikeda N; Koizumi K
Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):101-8. PubMed ID: 23474638
[TBL] [Abstract][Full Text] [Related]
10. Radiation doses to cohabitants of patients undergoing radioiodine ablation for thyroid cancer: poor compliance with radiation protection guidelines but low radiation exposure.
Gabriel S; Farman-Ara B; Bourrelly M; Carpentier O; Sebag F; Palazzo FF; De Micco C; Mancini J; Henry JF; Mundler O; Taïeb D
Nucl Med Commun; 2011 Sep; 32(9):829-33. PubMed ID: 21633315
[TBL] [Abstract][Full Text] [Related]
11. Radiation dose rates of differentiated thyroid cancer patients after
Jin P; Feng H; Ouyang W; Wu J; Chen P; Wang J; Sun Y; Xian J; Huang L
Radiat Environ Biophys; 2018 May; 57(2):169-177. PubMed ID: 29525896
[TBL] [Abstract][Full Text] [Related]
12. Potential third-party radiation exposure from outpatients treated with 131I for hyperthyroidism.
Matheoud R; Reschini E; Canzi C; Voltini F; Gerundini P
Med Phys; 2004 Dec; 31(12):3194-200. PubMed ID: 15651602
[TBL] [Abstract][Full Text] [Related]
13. Radiation dose rates from adult patients receiving 131I therapy for thyrotoxicosis.
O'Doherty MJ; Kettle AG; Eustance CN; Mountford PJ; Coakley AJ
Nucl Med Commun; 1993 Mar; 14(3):160-8. PubMed ID: 8455905
[TBL] [Abstract][Full Text] [Related]
14. Radioiodine therapy: care of the helpless patient and handling of the radioactive corpse.
Greaves C; Tindale W
J Radiol Prot; 2001 Dec; 21(4):381-92. PubMed ID: 11787894
[TBL] [Abstract][Full Text] [Related]
15. Thyroid cancer patients treated with 131I: radiation dose to relatives after discharge from the hospital.
Rémy H; Coulot J; Borget I; Ricard M; Guilabert N; Lavielle F; Camps E; Baudin E; Lumbroso J; Leboulleux S; Schlumberger M
Thyroid; 2012 Jan; 22(1):59-63. PubMed ID: 22136157
[TBL] [Abstract][Full Text] [Related]
16. First-day iodine kinetics is useful for individualizing radiation safety precautions for thyroid carcinoma patients.
Tenhunen M; Lehtonen S; Heikkonen J; Halonen P; Mäenpää H
Nucl Med Commun; 2013 Dec; 34(12):1208-15. PubMed ID: 24077636
[TBL] [Abstract][Full Text] [Related]
17. Are restrictions to behaviour of patients required following fluorine-18 fluorodeoxyglucose positron emission tomographic studies?
Cronin B; Marsden PK; O'Doherty MJ
Eur J Nucl Med; 1999 Feb; 26(2):121-8. PubMed ID: 9933345
[TBL] [Abstract][Full Text] [Related]
18. Radiation exposure to family members of patients with thyrotoxicosis treated with iodine-131.
Cappelen T; Unhjem JF; Amundsen AL; Kravdal G; Følling I
Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):81-6. PubMed ID: 16151768
[TBL] [Abstract][Full Text] [Related]
19. Estimation of external radiation dose to caregivers of patients treated with radioiodine after thyroidectomy.
Jeong KH; Jung JW; Kim CB; Ahn BC; Lee HK; Yoo SJ; Day O; Lee JK
Health Phys; 2014 Apr; 106(4):466-74. PubMed ID: 24562067
[TBL] [Abstract][Full Text] [Related]
20. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.
Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F
Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
